trans-Dehydrocrotonin (t-DCTN), the diterpenoid from Croton cajucara Bentham, exhibits hypoglycemic and hypolipidemic activities, but in high doses is associated with a discrete hepatotoxicity. In the search for measures to mitigate this, pretreatment with the antioxidants N-acetylcysteine and vitamin E has been examined. Mice that received a high dose t-DCTN (100 mg/kg) manifested hepatic damage, as evidenced by significant elevations in serum ALT and AST, and hepatic GSH, and histological alterations, which could be obliterated by pretreatment with vitamin E, but not with N-acetylcysteine, possibly by creating an effective antioxidant balance.
Hepatotoxicity due to herbal remedies is a major concern throughout the world because of their wide use and easy availability [1] . It also remains the major reason for drug withdrawal from pharmaceutical development and clinical use. Croton cajucara Benth. (Euphorbiaceae) is a popular medicinal plant largely consumed in Brazil in the form of either teas or pills to combat diabetes, stomach complaints, obesity, and to treat inflammatory conditions of liver and kidneys. Studies on trans-dehydrocrotonin (t-DCTN), a clerodane-type diterpene (Figure 1 ) isolated from the stem bark of this plant revealed a remarkable pharmacological profile that include hypoglycemic and hypolipidemic properties, validating the traditional use of this plant in diabetes control and as a slimming dietary agent [2a,2b] . In addition, there have been reports that t-DCTN is devoid of genotoxicity and could even induce an antigenotoxic effect [3a,3b] . Thus, studies performed on t-DCTN indicate a therapeutic perspective for drug development. However, a few studies indicated the likely hepatotoxicity-inducing potential of this diterpene through animal experimentation [4] . The conventional antidiabetic agents, glitazones, metformin and acarbose have been reported to cause rare but severe hepatotoxicity, which sometimes results in liver failure leading to the need for liver transplantation, or even death [5a,5b] .
Like C. cajucara, Teucrium species, such as germander (T. chamaedrys L. and T. canadense L.), are rich in either clerodane or neoclerodane diterpenoids, which account for the hepatotoxicity potential of these botanicals [6] . Some of these plant-derived diterpenoids may induce hepatotoxicity, possibly by acting as prooxidants attacking macromolecules including protein, DNA and lipids. Antioxidant vitamins, like vitamin E (Vit-E) and sulfhydryl donors, such as N-acetyl cysteine (NAC) may counter the oxidative stress and are likely to prevent liver damage. As part of our continuation study, we report the hepatotoxic potential of t-DCTN through a dose-response study and its potential amelioration by Vit-E. and NAC.
Compared with the vehicle-treated control group, significant increases in the serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were observed in groups of mice that received single or repeated oral doses of t-DCTN at 100, and 300 mg/kg, but not at 10 and 30 mg/kg ( Figure 2 ). In contrast, the hepatic reduced glutathione (GSH) showed an increasing trend at all dose levels of t-DCTN, but attained statistical significance only at 30, 100, and 300 mg/kg.
These results are in agreement with the previously reported findings on its high-dose associated liver damage [4] . Following the single oral 100 mg/kg t-DCTN dose, when compared with the control group, significant elevations in serum levels of AST (1.9-fold) and ALT (3.6-fold), and in hepatic thiobarbituric acid- Vit-E (300 mg/kg, p.o.), but not NAC (150 mg/kg, i.p.) pretreatment greatly suppressed the elevations in serum ALT and AST to the levels seen in vehicle controls Furthermore, it caused a significant decrease (2.9-fold) in hepatic TBARS formation induced by 100 mg/kg t-DCTN. Figure 5 depicts the effects of vehicle and test drugs on hepatic catalase activity. Vit-E, but not NAC, significantly increased the catalase activity. The combined Vit-E and NAC treatment, although found to be effective, was not additive in combating t-DCTNinduced alterations in biochemical parameters. Figure 6 shows the histological alterations induced by t-DCTN and the pretreatment effects of Vit-E and NAC. Changes related to hepatocellular damage were more pronounced in mice that received the high dose of t-DCTN (100 mg/kg) than the low-dose ( Figure 6B ). Histological sections taken from the vehicle treated mice ( Figure 6A ), when compared with those from high-dose t-DCTN treated animals presented extensive areas of necrosis, cloudy degeneration, and inflammatory foci, with a predominance of polymorphonuclear cells ( Figure 6C ). These changes induced by a high dose of t-DCTN were greatly diminished in the group of animals pretreated with Vit-E ( Figure 6E ), but not in the NAC group ( Figure 6D) . Necrosis, which is a more severe form of injury, was either markedly prevented or minimized by pretreatment with Vit-E. The effects of combination therapy (NAC + Vit-E) on hepatocellular changes were however, similar to those seen with Vit-E alone. The parenchymal architecture was well preserved by all treatments with the exception of the animal group that received t-DCTN (100 mg/kg). Thus the data obtained in this study clearly project the hepatotoxicity potential of t-DCTN, as evidenced by elevated serum ALT and AST, hepatic glutathione and TBARS, as well as histological observations that basically support the results obtained from serum enzyme assays.
As regards to hepatotoxicity, t-DCTN might have altered the redox balance towards a more oxidized state in the liver, acting in a pro-oxidant manner, reducing the antioxidant cell defense and creating oxidative stress, a deleterious process that can be an important mediator of damage to cell structures, including lipids and membranes, proteins, and DNA [7] . In order to evaluate the relationship between oxidative stress and t-DCTN-associated liver injury, we evaluated the possible changes of GSH, TBARS and catalase activity in liver tissues. The results show that t-DCTN at a high dose (100 mg/kg) can significantly enhance the GSH content and TBARS formation in liver tissue, indicating an ongoing oxidative stress. The rise in the activity of GSH observed in our study could be due to its induction to counter the effect of increased oxidative stress. The auto-oxidation of GSH yields super oxide (O -2 ), hydroxy radical (-OH), and H 2 O 2 [8] . Thus the generation of free radicals in the absence of scavenging defenses like super oxide dismutase, glutathione peroxidase and catalase might promote increased lipid peroxidation that eventually contributes to liver damage in t-DCTN-treated animals. Therefore, we thought that a compound with antioxidant properties can therapeutically ameliorate the progression of lipid peroxidation and hepatocellular injury induced by t-DCTN. Vit-E and NAC are clinically useful antioxidants that protect the body against oxidative stress. It is well-known that Vit-E deficiency increases lipid peroxidation in liver tissue and its supplementation alters lipid oxidation in vivo [9] whereas NAC, a cysteine prodrug, replenishes intracellular GSH levels. NAC, best known for its ability to counter acetaminophen toxicity, is a safe, well-tolerated antidote for cysteine/GSH deficiency [10] . Also studies suggest an interaction between GSH and Vit-E in protecting against lipid peroxidation [11] . In this investigation, both biochemical and histological analyses show that NAC (150 mg/kg) treatment neither ameliorates the hepatotoxic effect of t-DCTN nor potentiates the protection offered by Vit-E. Vit-E provides an effective protective mechanism against cytosolic injury caused by oxidative stress, because it stimulates catalase [12] and eliminates H 2 O 2 and lipid peroxides by utilizing GSH. Vit-E markedly lowered the hepatotoxicity of t-DCTN, evidenced by decreased levels of serum ALT, AST, and hepatic TBARS contents with an increased catalase activity, and reduced the severity of histological alterations. The present findings are in agreement with an earlier study [13] that addressed the protective effect of Vit-E, but not of NAC on the hepatocellular damage. In summary, the present investigation reveals that t-DCTN at a high dose can increase oxidative stress and promote lipid peroxidation. The increase in hepatic GSH might be a cause of host defense against ongoing oxidative stress. Since Vit-E protected liver damage against lipid peroxidation and restored TBARS, AST and ALT to nearly normal levels, with enhanced levels of catalase activity, lipid peroxidation may be the prime cause of hepatocellular damage in t-DCTN treated mice. It seems justified to use Vit-E as an adjunct agent to combat liver damage associated with high-dose t-DCTN. 
Chemicals and drug dilutions:
The following drugs were used: N-acetylcysteine (NAC), Ellman´s reagent DTNB (5,5'-dithiobis-2-nitrobenzoic acid), glutathione (GSH), thiobarbituric acid (Sigma, Chemical Company, St. Louis, MO, USA). Vitamin E (Vit-E) was purchased from Aché (São Paulo, Brazil). All other chemicals used were of analytical grade (PA). The diterpene, t-DCTN was isolated from the stem bark of Croton cajucara Benth., as described earlier [14] . The purity of t-DCTN was 99% (NMR analysis). t-DCTN was solubilized using 3% v/v Tween 80 in normal saline. The control groups received t-DCTN vehicle. NAC was diluted in normal saline. Vit-E was suspended in corn oil and no vehicle-treated control was included in the study since pilot studies had revealed no significant effect per se of corn oil.
